Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics

NCT01188577 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma
Bronchospasm
Wheezing
Shortness of Breath

Interventions

DRUG: Epinephrine Inhalation Aerosol, HFA
DRUG: Epinephrine Inhalation Aerosol

Sponsor

Amphastar Pharmaceuticals, Inc.